| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | EVP, General Counsel | Common Stock | 517,934 | $8,261,047 | $15.95 | 02 Jan 2026 | Direct |
| Aurinia Pharmaceuticals Inc. | EVP, General Counsel | Employee Stock Option (right to buy) | 128,438 | 28 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | 02 Jan 2026 | 2 | -$644,141 | 4 | EVP, General Counsel | 05 Jan 2026, 16:13 |
| AUPH | Aurinia Pharmaceuticals Inc. | 28 Feb 2025 | 5 | -$975,223 | 4 | EVP, General Counsel | 04 Mar 2025, 20:57 |
| AUPH | Aurinia Pharmaceuticals Inc. | 06 Mar 2024 | 1 | -$323,372 | 4 | EVP, General Counsel | 07 Mar 2024, 16:41 |
| AUPH | Aurinia Pharmaceuticals Inc. | 20 Feb 2024 | 1 | $0 | 4 | EVP, General Counsel | 22 Feb 2024, 16:29 |
| AUPH | Aurinia Pharmaceuticals Inc. | 02 Mar 2023 | 1 | -$172,474 | 4/A | EVP, General Counsel | 22 Feb 2024, 16:19 |
| AUPH | Aurinia Pharmaceuticals Inc. | 02 Mar 2023 | 2 | -$173,454 | 4 | EVP, General Counsel | 06 Mar 2023, 15:29 |
| AUPH | Aurinia Pharmaceuticals Inc. | 02 Mar 2022 | 3 | $0 | 4 | EVP, General Counsel | 04 Mar 2022, 15:11 |